Before you start training to gorge at your game day party, tackle this month’s selection of notable news stories, intercepted for you from the Drug Channels gridiron:
- Offsides: My $0.02 on the latest moves by Amazon and OptumRx
- Trick play: OptumRx attacks alternative funding programs
- Offensive line: Shocking Wall Street Journal expose of 340B abuses
- Touchdown! Accumulators and maximizers go mainstream
P.S. Join the nearly 37,000 people who run after me on LinkedIn. You can also chase me at @DrugChannels on Twitter. Every day, I tackle links to neat stuff for you.